Australia Pushes For More Drug Repurposing
Consultation Document Lays Out Regulatory And Legislative Options
Executive Summary
Proposals on how to encourage more applications for new uses of repurposed drugs could see some significant changes, including an obligation on sponsors to file for new indications.
You may also be interested in...
Australia Proposes Incentives For Drug Repurposing
Dealing with IP issues, identifying and shortlisting candidates, and agreeing on appropriate incentives are among the topics addressed in a new Australian consultation on the repurposing of medicines.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.
New HTA Evidence Guidelines In EU Could Spell Trouble For Advanced Therapy Companies
New guidelines that cast doubt over use of single-arm and non-randomized studies are “discouraging” for rare disease patients and the advanced therapy sector, says ARM, the Alliance for Regenerative Medicines.